114 related articles for article (PubMed ID: 12100693)
21. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
Romano C; Rubegni P; Ghilardi A; Fimiani M
Mycoses; 2006 May; 49(3):249-50. PubMed ID: 16681820
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.
Elewski B; Bergstresser PR; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):290-2. PubMed ID: 7829722
[No Abstract] [Full Text] [Related]
23. In vitro antifungal susceptibility of dermatophyte strains causing tinea pedis and onychomycosis in patients with non-insulin-dependent diabetes mellitus: a case-control study.
Ozcan D; Seçkin D; Demirbilek M
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1442-6. PubMed ID: 20384680
[TBL] [Abstract][Full Text] [Related]
24. Tinea pedis caused by Hendersonula toruloidea. A new problem in dermatology.
Greer DL; Gutierrez MM
J Am Acad Dermatol; 1987 May; 16(5 Pt 2):1111-5. PubMed ID: 2953766
[TBL] [Abstract][Full Text] [Related]
25. Hyperkeratotic chronic tinea pedis treated with neticonazole cream. Neticonazole Study Group.
Tsuboi R; Matsumoto T; Ogawa H
Int J Dermatol; 1996 May; 35(5):371-3. PubMed ID: 8734665
[No Abstract] [Full Text] [Related]
26. Therapy of tinea nigra plantaris.
Sayegh-Carreño R; Abramovits-Ackerman W; Girón GP
Int J Dermatol; 1989; 28(1):46-8. PubMed ID: 2917812
[TBL] [Abstract][Full Text] [Related]
27. Clinical antifungal activity of thiabendazole.
Battistini F; Zaias N; Sierra R; Rebell G
Arch Dermatol; 1974 May; 109(5):695-9. PubMed ID: 4275184
[No Abstract] [Full Text] [Related]
28. Tinea pedis: diagnosis and treatment.
Brooks KE; Bender JF
Clin Podiatr Med Surg; 1996 Jan; 13(1):31-46. PubMed ID: 8849930
[TBL] [Abstract][Full Text] [Related]
29. Use of naftifine hydrochloride 2% cream and 39% urea cream in the treatment of tinea pedis complicated by hyperkeratosis.
Kircik LH; Onumah N
J Drugs Dermatol; 2014 Feb; 13(2):162-5. PubMed ID: 24509966
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
[TBL] [Abstract][Full Text] [Related]
31. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.
James IG; Loria-Kanza Y; Jones TC
J Dermatolog Treat; 2007; 18(3):163-8. PubMed ID: 17538805
[TBL] [Abstract][Full Text] [Related]
32. [Skin erosion of the heel].
Vermeulen C; Hauser C
J Dtsch Dermatol Ges; 2003 Feb; 1(2):153-4. PubMed ID: 16285185
[No Abstract] [Full Text] [Related]
33. Antifungal activity of the new agent latoconazole in two tinea models.
Ohmi T; Konaka S; Uchida M; Yamaguchi H
Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
Ablon G; Rosen T; Spedale J
Int J Dermatol; 1996 Aug; 35(8):591-3. PubMed ID: 8854165
[No Abstract] [Full Text] [Related]
35. Tinea pedis acquired in mosques?
Veraldi S; Esposito L; Gorani A
Mycoses; 2018 Nov; 61(11):794-795. PubMed ID: 29600810
[TBL] [Abstract][Full Text] [Related]
36. Identifying Signs of Tinea Pedis: A Key to Understanding Clinical Variables.
Canavan TN; Elewski BE
J Drugs Dermatol; 2015 Oct; 14(10 Suppl):s42-7. PubMed ID: 26461834
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L
J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and treatment of palmoplantar keratoderma and tinea pedis in patients with Sézary syndrome.
Martin SJ; Duvic M
Int J Dermatol; 2012 Oct; 51(10):1195-8. PubMed ID: 22994666
[TBL] [Abstract][Full Text] [Related]
39. Topical treatment for moccasin-type tinea pedis.
Greer DL
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):554-8. PubMed ID: 3546420
[TBL] [Abstract][Full Text] [Related]
40. A comparative trial of chlorphenesin and pecilocin in a prison community.
Harris C; Philpot CM
Br J Clin Pract; 1969 Nov; 23(11):449-51. PubMed ID: 4900295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
